Ocular Therapeutix Inc
NASDAQ:OCUL
Ocular Therapeutix Inc
EPS (Diluted)
Ocular Therapeutix Inc
EPS (Diluted) Peer Comparison
Competitive EPS (Diluted) Analysis
Latest Figures & CAGR of Competitors
Company | EPS (Diluted) | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Ocular Therapeutix Inc
NASDAQ:OCUL
|
EPS (Diluted)
$0
|
CAGR 3-Years
20%
|
CAGR 5-Years
10%
|
CAGR 10-Years
0%
|
|
Johnson & Johnson
NYSE:JNJ
|
EPS (Diluted)
$15
|
CAGR 3-Years
41%
|
CAGR 5-Years
24%
|
CAGR 10-Years
12%
|
|
Bristol-Myers Squibb Co
NYSE:BMY
|
EPS (Diluted)
-$3
|
CAGR 3-Years
-3%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Pfizer Inc
NYSE:PFE
|
EPS (Diluted)
$0
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Merck & Co Inc
NYSE:MRK
|
EPS (Diluted)
$0
|
CAGR 3-Years
-31%
|
CAGR 5-Years
-23%
|
CAGR 10-Years
-5%
|
|
Eli Lilly and Co
NYSE:LLY
|
EPS (Diluted)
$6
|
CAGR 3-Years
0%
|
CAGR 5-Years
1%
|
CAGR 10-Years
7%
|
See Also
What is Ocular Therapeutix Inc's EPS (Diluted)?
EPS (Diluted)
-0.9
USD
Based on the financial report for Mar 31, 2024, Ocular Therapeutix Inc's EPS (Diluted) amounts to -0.9 USD.
What is Ocular Therapeutix Inc's EPS (Diluted) growth rate?
EPS (Diluted) CAGR 10Y
0%
Over the last year, the EPS (Diluted) growth was 24%. The average annual EPS (Diluted) growth rates for Ocular Therapeutix Inc have been 20% over the past three years , 10% over the past five years .